Drug Profile
NMSO 3
Alternative Names: NMSO3Latest Information Update: 10 Oct 2012
Price :
$50
*
At a glance
- Originator Fukushima Medical University; Nissin Food Products
- Developer Fukushima Medical University; Microbiotix; Nissin Food Products; University of Texas Medical Branch
- Class Antivirals; Lipids; Sulfates
- Mechanism of Action CD4 antigen inhibitors; Virus attachment inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections; Metapneumovirus infections; Rotavirus infections
Most Recent Events
- 10 Oct 2012 No development reported - Preclinical for HIV infections in Japan (unspecified route)
- 10 Oct 2012 No development reported - Preclinical for Metapneumovirus-infections in USA (Intranasal)
- 10 Oct 2012 No development reported - Preclinical for Rotavirus infections in Japan (PO)